Machine learning in medicine: Addressing ethical challenges
- PMID: 30399149
- PMCID: PMC6219763
- DOI: 10.1371/journal.pmed.1002689
Machine learning in medicine: Addressing ethical challenges
Abstract
Effy Vayena and colleagues argue that machine learning in medicine must offer data protection, algorithmic transparency, and accountability to earn the trust of patients and clinicians.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: EV has received speaking fees from SwissRe, Novartis R&D Academy, and Google Netherlands. IGC served as a consultant for Otsuka Pharmaceuticals advising on the use of digital medicine for its Abilify MyCite product. IGC is supported by the Collaborative Research Program for Biomedical Innovation Law, which is a scientifically independent collaborative research program supported by Novo Nordisk Foundation. AB served as a consultant for Celgene Corporation for the preparation of a workshop on pharmaceutical innovation and received honoraria from SwissRe for participating at an internal event on genome editing.
Figures
References
-
- Fenech M, Strukelj N, Buston O. Ethical, social and polictical challenges of artificial intelligence in health. 2018 April [Cited 19 Sept 2018]. http://futureadvocacy.com/wp-content/uploads/2018/04/1804_26_FA_ETHICS_0....
-
- Intel Corporation. Overcoming barriers in AI adoption in healthcare. 2018 April [Cited Sept 19, 2018]. https://newsroom.intel.com/wp-content/uploads/sites/11/2018/07/healthcar....
MeSH terms
LinkOut - more resources
Full Text Sources
